Skip to main content

Enterprise Protection CVE-2023-0089

HIGH
Eval Injection (CWE-95)
2023-03-08 security@proofpoint.com
8.8
CVSS 3.1 · NVD
Share

Severity by source

NVD PRIMARY
8.8 HIGH
AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
Network
Attack Complexity
Low
Privileges Required
Low
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

Lifecycle Timeline

1
CVE Published
Mar 08, 2023 - 01:15 nvd
HIGH 8.8

DescriptionNVD

The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to execute remote code through 'eval injection'.

This affects all versions 8.20.0 and below.

AnalysisAI

The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to execute remote code through 'eval injection'. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-95. The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to execute remote code through 'eval injection'. This affects all versions 8.20.0 and below. Affected products include: Proofpoint Enterprise Protection.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

Share

CVE-2023-0089 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy